본문으로 건너뛰기
← 뒤로

New Onset Heart Failure Induced by Glumetinib: A Case Report.

Clinical therapeutics 2026 Vol.48(4) p. 385-388

Li X, Zhang W, Wang Y, Yan J, Luo X, Chen J

📝 환자 설명용 한 줄

[PURPOSE] We present the first case report of new-onset heart failure associated with glumetinib.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Li X, Zhang W, et al. (2026). New Onset Heart Failure Induced by Glumetinib: A Case Report.. Clinical therapeutics, 48(4), 385-388. https://doi.org/10.1016/j.clinthera.2026.02.009
MLA Li X, et al.. "New Onset Heart Failure Induced by Glumetinib: A Case Report.." Clinical therapeutics, vol. 48, no. 4, 2026, pp. 385-388.
PMID 41864774

Abstract

[PURPOSE] We present the first case report of new-onset heart failure associated with glumetinib.

[METHODS] The Naranjo Adverse Drug Reaction Probability Scale was used to assess causality.

[FINDINGS] The Naranjo scale generated a score of 7, suggesting a probable association between heart failure and glumetinib therapy. This may result from HGF/MET pathway inhibition, compromising cardiomyocyte self-protection and causing direct cardiac toxicity.

[IMPLICATIONS] A probable association exists between heart failure and glumetinib.

MeSH Terms

Humans; Heart Failure; Male; Protein Kinase Inhibitors; Female; Pyrazoles; Pyridines

같은 제1저자의 인용 많은 논문 (5)